P. Ruff

Josep Tabernero, Jean-Yves Douillard, David Cunningham, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

J. Tabernero, J. Canon, G. Bodoky, 2016, ESMO Open.

Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans

P. Ruff, F. Sitas, M. Hale, 2008, British Journal of Cancer.

Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans

P. Ruff, F. Sitas, M. Hale, 2008, British Journal of Cancer.

Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV.

A. Neugut, J. Jacobson, P. Ruff, 2019, Breast.

Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans

P. Ruff, F. Sitas, M. Hale, 2008, British Journal of Cancer.

Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans

V. Beral, P. Ruff, F. Sitas, 2002, British Journal of Cancer.

A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma.

P. Ruff, M. Chasen, J. Long, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix , anogenital organs , oral cavity and pharynx , oesophagus and prostate in a black South African population

V. Beral, P. Ruff, F. Sitas, 2015 .

Low socioeconomic status and risk for infection with Human Herpesvirus 8 among HIV-1 negative, South African black cancer patients

P. Ruff, F. Sitas, D. Bourboulia, 2004, Epidemiology and Infection.

A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.

J. Bruix, J. Llovet, P. Ruff, 2001, European journal of cancer.

Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells.

P. Ruff, P. Arbuthnot, Luigi Zampieri, 2002, Anticancer research.

A Prospective Randomized Study of Chop Versus Chop Plus Alpha-2B Interferon in Patients with Intermediate and High Grade Non-Hodgkin's Lymphoma: The International Oncology Study Group NHL1 Study

Z. Aziz, P. Ruff, F. Giles, 2000, Leukemia & lymphoma.

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa.

V. Beral, P. Ruff, F. Sitas, 1997, British Journal of Cancer.

An overview of cancer research in South African academic and research institutions, 2013 - 2014.

P. Ruff, J. Moodley, V. Sewram, 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa

A. Neugut, J. Jacobson, P. Ruff, 2021, Breast Cancer Research and Treatment.

SSCP analysis of the tyrosine kinase domain of the insulin receptor gene: Polymorphisms detected in South African black and white subjects

M. Kedda, P. Ruff, V. Panz, 1996, Human Genetics.

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11.

A. Neugut, V. McCormack, J. Jacobson, 2018, Cancer epidemiology.

Recommendations for the management of adult chronic myeloid leukaemia in South Africa.

P. Ruff, L. Dreosti, V. Louw, 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Epidemic AIDS-related Kaposi's sarcoma in southern Africa: experience at the Johannesburg General Hospital (1980-1990).

P. Ruff, W. Bezwoda, M. Stein, 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care

M. Gnant, P. Ruff, C. Hendricks, 2021, JCO global oncology.

Computerized Dental Injection Fear Treatment

S. Coldwell, B. Leroux, P. Ruff, 2013, Journal of dental research.

ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply.

P. Ruff, M. Peeters, T. Price, 2014, The Lancet. Oncology.

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.

Marc Peeters, Tae Won Kim, P. Ruff, 2014, The Lancet. Oncology.

Quality of life (QoL) during first-line treatment with FOLFOX4 with or without panitumumab (pmab) in RAS wild-type (WT) metastatic colorectal carcinoma (mCRC).

J. Tabernero, J. Canon, G. Bodoky, 2015 .

O-0011FREQUENCY OF S492R MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR: ANALYSIS OF PLASMA DNA FROM METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH PANITUMUMAB OR CETUXIMAB MONOTHERAPY

Tae Won Kim, P. Ruff, M. Boedigheimer, 2014 .

A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy

P. Ruff, C. Nyongesa, B. Donde, 2006, International Journal of Gynecologic Cancer.

The South African Bone Marrow Registry (SABMR) and allogeneic bone marrow transplantation.

P. Ruff, E. D. du Toit, T. Schlaphoff, 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Amyloidosis: A changing clinical perspective

P. Ruff, E. Mansvelt, P. Jacobs, 2007, Hematology.

Precursor T‐cell lymphoma associated with human immunodeficiency virus type 1 (HIV‐1) infection. First reported case

A. Bagg, P. Ruff, K. Papadopoulos, 1989, Cancer.

Anticancer Activity of Novel Gabexate Mesilate Mimetics in Colorectal Cancer Cells

P. Ruff, C. Penny, A. S. Al-Bogami, 2018, ChemistrySelect.

Impact of HIV infection on survival among women with stage I‐III breast cancer: Results from the South African breast cancer and HIV outcomes study

A. Neugut, V. McCormack, J. Jacobson, 2022, International journal of cancer.

Patterns of clonal evolution in transformed chronic myelogenous leukemia.

P. Ruff, E. Saragas, A. Weaving, 1995, Cancer genetics and cytogenetics.

Brief communication: Minimally invasive bone sampling method for DNA analysis.

P. Ruff, C. Penny, G. Štrkalj, 2009, American journal of physical anthropology.

Novel methods of molecular sex identification from skeletal tissue using the amelogenin gene.

P. Ruff, C. Penny, G. Štrkalj, 2009, Forensic science international. Genetics.

A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa.

P. Ruff, W. Bezwoda, M. Stein, 1996, American journal of clinical oncology.

Colorectal cancer in South Africa study on the effect of delayed diagnosis to treatment intervals on survival

P. Ruff, C. Bouter, H. Etheredge, 2022, South African Journal of Surgery.

The sex profile of skeletal remains from a cemetery of chinese indentured labourers in South Africa

P. Ruff, C. Penny, G. Štrkalj, 2010 .

Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals

A. Neugut, P. Ruff, C. Hur, 2021, JCO Global Oncology.

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

J. Tabernero, J. Jassem, J. Canon, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Spiritual care, pain reduction and preferred place of death among advanced cancer patients in Soweto, South Africa.

A. Neugut, H. Prigerson, J. Jacobson, 2020, Journal of pain and symptom management.

Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient.

P. Ruff, J. Kallenbach, J. Abramowitz, 1985, Chest.

Radiation therapy in endemic (African) Kaposi's sarcoma.

A. Kuten, P. Ruff, W. Bezwoda, 1993, International journal of radiation oncology, biology, physics.

Endemic African Kaposi's sarcoma: clinical and therapeutic implications. 10-year experience in the Johannesburg Hospital (1980-1990).

P. Ruff, W. Bezwoda, P. Macphail, 1994, Oncology.

Radiation Therapy in an Elderly African Population with Kaposi's Sarcoma

P. Ruff, J. Dale, M. Stein, 1994, Tumori.

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?

P. Ruff, C. Penny, R. Shahbazi, 2023, Frontiers in Oncology.

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kazuhiro Yoshida, A. Benson, Y. Bang, 2018, The Lancet.

Guidelines for the treatment of myelodysplastic syndromes (MDS) in South Africa.

P. Ruff, J. Mahlangu, E. Verburgh, 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV

A. Neugut, J. Jacobson, P. Ruff, 2020, BMC Gastroenterology.

A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection

A. Neugut, J. Jacobson, P. Ruff, 2020, Breast Cancer Research and Treatment.

Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia).

P. Ruff, R. Sandyk, M. Brennan, 1982, British medical journal.

The treatment of AIDS-related cancers.

R. Ashcroft, P. Ruff, A. Levine, 2003, The Lancet. Oncology.

Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy

A. Neugut, J. Jacobson, P. Ruff, 2018, The oncologist.

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

E. Van Cutsem, J. Tabernero, P. Ruff, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC).

Tae Won Kim, P. Ruff, M. Boedigheimer, 2015 .

South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment

A. Neugut, W. Tsai, S. Norris, 2016, Journal of global oncology.

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen

P. Ruff, J. Raats, L. Burgess, 2009, Cancer Chemotherapy and Pharmacology.

Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature.

Jeremy C. Sinkin, P. Ruff, K. Patel, 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa

A. Neugut, J. Jacobson, P. Ruff, 2017, PloS one.

CD133/EpCAM Cancer Stem Cell Markers of Tumour Stage in Colorectal Cancer Cells

P. Ruff, C. Penny, P. Kay, 2015 .

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

A. Neugut, J. Jacobson, P. Ruff, 2018, Cancer management and research.

The spectrum of HIV‐1 related cancers in South Africa

V. Beral, M. Connor, P. Ruff, 2000, International journal of cancer.

The spectrum of human immunodeficiency virus‐associated cancers in a South African black population: Results from a case–control study, 1995–2004

V. Beral, P. Ruff, F. Sitas, 2008, International journal of cancer.

Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: A case control study

V. Beral, A. Berrington de González, P. Ruff, 2006, Infectious Agents and Cancer.

Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study

A. Neugut, V. McCormack, S. Norris, 2023, Breast Cancer Research.

Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort

A. Neugut, V. McCormack, S. Norris, 2022, PloS one.

The Impact of Breast Cancer Treatment Delays on Survival Among South African Women

A. Neugut, V. McCormack, J. Jacobson, 2022, The oncologist.

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

J. Carmichael, P. Ruff, N. Davidson, 2004, BMC Cancer.

The Looming Threat: Cancer in Sub‐Saharan Africa

A. Neugut, W. El-Sadr, P. Ruff, 2021, The oncologist.

It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort.

P. Ruff, C. Bouter, H. Etheredge, 2020, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The multimorbidity profile of South African women newly diagnosed with breast cancer

A. Neugut, V. McCormack, S. Norris, 2020, International journal of cancer.

Establishment of a cancer surveillance programme: the South African experience.

P. Ruff, C. Babb, M. Sengayi, 2015, The Lancet. Oncology.

Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group Study

P. Ruff, J. Forster, L. Goedhals, 1994 .

Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group.

P. Ruff, P. Pouillart, L. Goedhals, 1994, Oncology.

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

C. Porta, P. Ruff, R. Gish, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Access to Cancer Therapeutics in Low- and Middle-Income Countries.

P. Ruff, L. Shulman, Charmaine L. Blanchard, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

T-Cell Prolymphocytic Leukaemia : A Case Series

P. Ruff, J. Vaughan, E. Schapkaitz, 2017 .

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial.

E. Van Cutsem, J. Tabernero, P. Ruff, 2014, European journal of cancer.

Scientific fraud and international research.

P. Ruff, L. Goedhals, R. Abratt, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III study of panitumumab (pmab) with FOLFOX4 compared to FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): PRIME trial analysis by epidermal growth factor receptor (EGFR) tumor staining.

J. Tabernero, P. Ruff, D. Cunningham, 2010 .

Adjuvant trastuzumab in early HER2-positive breast cancer: Journeying towards the optimal duration of therapy in South Africa.

P. Ruff, M. Blockman, R. Wiseman, 2020, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Quality indicators for the diagnosis and surgical management of breast cancer in South Africa

S. Norris, P. Ruff, W. Chen, 2020, Breast.

Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy

Tae Won Kim, P. Ruff, M. Boedigheimer, 2020, Cancer biology & therapy.

Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast Units

S. Norris, P. Ruff, S. Nayler, 2021, JCO global oncology.

Access to colorectal cancer (CRC) chemotherapy and the associated costs in a South African public healthcare patient cohort

P. Ruff, S. Moch, J. Miot, 2018 .

Correlation of survival with tumor histology, age, and prognostic risk group for previously untreated patients with advanced renal cell carcinoma (adv RCC) receiving temsirolimus (TEMSR) or interferon-alpha (IFN)

A. Berkenblit, A. Strahs, P. Ruff, 2007 .

Ef ﬁ cacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

J. Jassem, J. Canon, Y. Humblet, 2014 .

KEYNOTE-555 Cohort B: Efficacy, safety, and PK of pembrolizumab (pembro) 400 mg every 6 weeks (Q6W) as 1L therapy for advanced melanoma.

James R. Anderson, A. Arance, P. Ruff, 2021 .

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

J. Tabernero, J. Jassem, J. Canon, 2014 .

Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study

P. Gibbs, Tae Won Kim, P. Ruff, 2018, Clinical Cancer Research.

Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G

T. Yamanaka, Susumu Nakata, Tae Won Kim, 2020, Cancers.

Validating an Instrument for Direct Patient Reporting of Distress and Chemotherapy-Related Toxicity among South African Cancer Patients

M. Antoni, P. Ruff, G. Lopes, 2021, Cancers.

Consensus study on the health system and patient-related barriers for lung cancer management in South Africa

S. Norris, T. Boyles, P. Ruff, 2021, PloS one.

A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern Africa.

A. Neugut, H. Prigerson, J. Jacobson, 2019, Journal of pain and symptom management.

Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.

E. Van Cutsem, P. Ruff, G. van Hazel, 2018, Journal of geriatric oncology.

Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa

A. Neugut, H. Prigerson, J. Jacobson, 2018, Journal of global oncology.

Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining

P. Ruff, T. Ngoma, W. Ngwa, 2021, JCO global oncology.

Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer

A. Neugut, C. Masimirembwa, P. Ruff, 2023, Clinical pharmacology and therapeutics.

The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa

A. Neugut, J. Jacobson, C. Masimirembwa, 2022, Breast Cancer Research and Treatment.

The South African National Cancer Registry: an update.

P. Ruff, C. Babb, M. Sengayi, 2014, The Lancet. Oncology.

Analysis of overall survival and safety during the course of the phase III VELOUR trial comparing FOLFIRI and ziv-aflibercept or placebo in mCRC patients who progressed on prior oxaliplatin treatment.

P. Ruff, R. Lakomy, E. Cutsem, 2013 .

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer

A. Neugut, P. Ruff, H. Cubasch, 2023, Breast Cancer Research and Treatment.

Breast Cancer Care Quality in South Africa’s Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures

A. Neugut, J. Jacobson, P. Ruff, 2019, Journal of global oncology.

Perspectives on common chronic diseases in adult cancer patients in South Africa

S. Norris, P. Ruff, H. Cubasch, 2023, Global health action.

Analysis of KRAS/NRAS and BRAF mutations in the phase III PRIME study of panitumumab (pmab) plus FOLFOX versus FOLFOX as first-line treatment (tx) for metastatic colorectal cancer (mCRC).

Scott D. Patterson, Josep Tabernero, Jean-Yves Douillard, 2013 .

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours

E. Raymond, J. Šufliarský, P. Ruff, 2018, Neuroendocrinology.

Phase II study of i.v. vinflunine as second line in patients with metastatic breast cancer after anthracycline-taxane failure.

M. Campone, P. Ruff, P. Fumoleau, 2004, Journal of Clinical Oncology.

The spectrum of HIV-associated cancers in a South African black population: results from a case-control study, 1995–2004

P. Ruff, F. Sitas, D. O’Connell, 2009, Infectious Agents and Cancer.

Breast cancer trends differ by ethnicity: a report from the South African National Cancer Registry (1994–2009)

S. Norris, P. Ruff, H. Cubasch, 2016, European journal of public health.

Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death.

A. Neugut, H. Prigerson, J. Jacobson, 2018, Journal of pain and symptom management.

Antibodies against human herpesvirus 8 in black South African patients with cancer.

V. Beral, C. Boshoff, R. Weiss, 1999, The New England journal of medicine.

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa

A. Neugut, P. Ruff, Yoanna S. Pumpalova, 2023, Cancer medicine.

3PEGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER IN SOUTH AFRICA

P. Ruff, C. Maske, S. W. Chan, 2015 .

Burn-injured patients - the preferably unheard.

P. Ruff, C. Bouter, H. Etheredge, 2022, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

Design and methodology of a study on colorectal cancer in Johannesburg, South Africa

P. Ruff, C. Penny, J. Fabian, 2018, JGH open : an open access journal of gastroenterology and hepatology.

Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research

S. Madhi, P. Ruff, M. Papathanasopoulos, 2023, PLOS global public health.

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

J. Tabernero, J. Jassem, J. Canon, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Tae Won Kim, P. Ruff, M. Peeters, 2014, The Lancet. Oncology.

Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.

P. Ruff, C. Penny, J. Kandhavelu, 2018, MicroRNA.

Access to Cancer Therapeutics in Low- and Middle-Income Countries.

P. Ruff, L. Shulman, Charmaine L. Blanchard, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

The spectrum of human immunodeficiency virus‐associated cancers in a South African black population: Results from a case–control study, 1995–2004

V. Beral, P. Ruff, F. Sitas, 2008, International journal of cancer.

Tae Won Kim, P. Ruff, M. Peeters, 2016, European journal of cancer.

The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.

E. Raymond, Jianming Xu, P. Ruff, 2017 .

Infectious Agents and Cancer Open Access the Relationship between Anti-hpv-16 Igg Seropositivity and Cancer of the Cervix, Anogenital Organs, Oral Cavity and Pharynx, Oesophagus and Prostate in a Black South African Population

V. Beral, P. Ruff, F. Sitas, 2022 .

PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study

A. Neugut, P. Ruff, H. Cubasch, 2023, Breast Cancer Research and Treatment.

Bmc Infectious Diseases Risk Factors for High Anti-hhv-8 Antibody Titers (≥1:51,200) in Black, Hiv-1 Negative South African Cancer Patients: a Case Control Study

P. Ruff, F. Sitas, D. Bourboulia, 2022 .